Whalesbook
Max Healthcare is significantly expanding its presence in Uttar Pradesh by approving a Rs 1,400 crore investment for a new 712-bed hospital in Lucknow. Expected to open by FY30, this facility aims to meet growing healthcare demand and will be the company's second major presence in the city. This strategic move builds on a quarter that saw a modest 3% profit increase and a 10% rise in gross revenue. For the full fiscal year, network gross revenue reached Rs 10,538 crore, with net profit climbing 22% to Rs 1,631 crore for FY26.
Q4 Performance Highlights
In the fourth quarter, Max Healthcare's gross revenue rose 10% year-on-year to Rs 2,664 crore. Bed occupancy remained strong at 75%, with occupied bed days up 8%. Average revenue per occupied bed (ARPOB) saw a slight increase to Rs 77,900. While the operating margin dipped slightly to 26.8% due to investments in clinical talent, net profit (PAT) grew 3% to Rs 387 crore. Free cash flow from operations improved substantially to Rs 581 crore.
Valuation and Analyst Views
Max Healthcare's trailing 12-month P/E ratio is around 68.4 to 75.24, near its 10-year median. Analysts maintain a positive outlook, with a consensus target price of Rs 1,199.25 to Rs 1,250, and an overall 'Strong Buy' rating. However, some analysts note a risk of overvaluation, pointing to a 90x P/E in relation to mid-May 2026 targets.
Competitive Landscape and Financial Health
The healthcare sector is competitive, with players like Apollo Hospitals and Fortis Healthcare. Max Healthcare's P/E ratio is considerably higher than peers such as Kovai Medical Center (25.6x) and Narayana Hrudayalaya (26.5x). A return on equity of 13.9% over three years suggests potential capital deployment inefficiencies. The company's current ratio of 0.79 indicates possible short-term liquidity pressures. Generally, a P/E above 30 signifies a growth stock, implying high expectations for future growth.
Future Growth Plans
Beyond the Lucknow project, Max Healthcare is pursuing expansions in Mohali, Mumbai, and Delhi, as well as a new greenfield hospital in Gurgaon. These projects are expected to add about 20% to its current capacity. Analysts predict next quarter revenue around ₹26.21 billion INR and fiscal year revenue of ₹124.26 billion INR. The company has also recommended a final dividend of Rs 2 per equity share for FY25-26.